Search research articles
Contact Us
Filters
Showing results (261-270 of 278) with videos related to
Page
of 28
Sort By:
JAMA Network Open
|
November 22, 2024
Medication Exposure and Mortality in Patients With Schizophrenia
Sébastien Brodeur, Yohann M Chiu, Josiane Courteau, et al.
BMC Psychiatry
|
October 11, 2025
Psychotropic-associated delusional pseudo-gender dysphoria: a case report
Karim Abdel Aziz, Abeer Saleh Al Ammari, Mouza Sultan Alzaabi, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
|
July 31, 2021
Exploring cannabidiol effects on inflammatory markers in individuals with cocaine use disorder: a randomized controlled trial
Florence Morissette, Violaine Mongeau-Pérusse, Elie Rizkallah, et al.
Frontiers in Psychiatry
|
June 2, 2011
Evolution of Substance use, Neurological and Psychiatric Symptoms in Schizophrenia and Substance use Disorder Patients: A 12-Week, Pilot, Case-Control Trial with Quetiapine
Simon Zhornitsky, Emmanuel Stip, Joelle Desfossés, et al.
Neuroscience and Biobehavioral Reviews
|
December 4, 2022
Effectiveness of pharmacogenomic tests including CYP2D6 and CYP2C19 genomic variants for guiding the treatment of depressive disorders: Systematic review and meta-analysis of randomised controlled trials
Danilo Arnone, Omar Omar, Teresa Arora, et al.
Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie
|
May 8, 2007
Treating delusional disorder: a comparison of cognitive-behavioural therapy and attention placebo control
Kieron O'Connor, Emmanuel Stip, Marie-Claude Pélissier, et al.
Frontiers in Pharmacology
|
January 4, 2021
The Large Action of Chlorpromazine: Translational and Transdisciplinary Considerations in the Face of COVID-19
Emmanuel Stip, Tahir A Rizvi, Farah Mustafa, et al.
Clinical Schizophrenia & Related Psychoses
|
July 29, 2015
Sex, Age, Symptoms and Illness Duration and Their Relation with Gyrification Index in Schizophrenia
Adham Mancini-Marïe, Uicheul Yoon, Jose Jiminez, et al.
The Journal of International Medical Research
|
September 22, 2020
Measures of gluten-related reactivity in children with autism spectrum disorders in the absence of overt gastrointestinal symptoms: a pilot study from the United Arab Emirates
Mohamed Abdel-Maksoud, Dina Aly El-Gabry, Tahani Al Kayoumi, et al.
Journal of Psychiatry & Neuroscience : JPN
|
September 8, 2007
Changes in serum lipids, independent of weight, are associated with changes in symptoms during long-term clozapine treatment
Ric M Procyshyn, Kishor M Wasan, Allen E Thornton, et al.
Page
of 28
Search research articles
Search
Showing results (261-270 of 278) with videos related to
Sort By:
Page
of 28
JAMA Network Open
|
November 22, 2024
Medication Exposure and Mortality in Patients With Schizophrenia
Sébastien Brodeur, Yohann M Chiu, Josiane Courteau, et al.
BMC Psychiatry
|
October 11, 2025
Psychotropic-associated delusional pseudo-gender dysphoria: a case report
Karim Abdel Aziz, Abeer Saleh Al Ammari, Mouza Sultan Alzaabi, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
|
July 31, 2021
Exploring cannabidiol effects on inflammatory markers in individuals with cocaine use disorder: a randomized controlled trial
Florence Morissette, Violaine Mongeau-Pérusse, Elie Rizkallah, et al.
Frontiers in Psychiatry
|
June 2, 2011
Evolution of Substance use, Neurological and Psychiatric Symptoms in Schizophrenia and Substance use Disorder Patients: A 12-Week, Pilot, Case-Control Trial with Quetiapine
Simon Zhornitsky, Emmanuel Stip, Joelle Desfossés, et al.
Neuroscience and Biobehavioral Reviews
|
December 4, 2022
Effectiveness of pharmacogenomic tests including CYP2D6 and CYP2C19 genomic variants for guiding the treatment of depressive disorders: Systematic review and meta-analysis of randomised controlled trials
Danilo Arnone, Omar Omar, Teresa Arora, et al.
Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie
|
May 8, 2007
Treating delusional disorder: a comparison of cognitive-behavioural therapy and attention placebo control
Kieron O'Connor, Emmanuel Stip, Marie-Claude Pélissier, et al.
Frontiers in Pharmacology
|
January 4, 2021
The Large Action of Chlorpromazine: Translational and Transdisciplinary Considerations in the Face of COVID-19
Emmanuel Stip, Tahir A Rizvi, Farah Mustafa, et al.
Clinical Schizophrenia & Related Psychoses
|
July 29, 2015
Sex, Age, Symptoms and Illness Duration and Their Relation with Gyrification Index in Schizophrenia
Adham Mancini-Marïe, Uicheul Yoon, Jose Jiminez, et al.
The Journal of International Medical Research
|
September 22, 2020
Measures of gluten-related reactivity in children with autism spectrum disorders in the absence of overt gastrointestinal symptoms: a pilot study from the United Arab Emirates
Mohamed Abdel-Maksoud, Dina Aly El-Gabry, Tahani Al Kayoumi, et al.
Journal of Psychiatry & Neuroscience : JPN
|
September 8, 2007
Changes in serum lipids, independent of weight, are associated with changes in symptoms during long-term clozapine treatment
Ric M Procyshyn, Kishor M Wasan, Allen E Thornton, et al.
Page
of 28